FDA News
🇪🇺 EMA Page 2EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 13–24 of 53 articles
EU Commission Advances Critical Medicines Act: Market Implications
FDA · 7 min
Dr. Elena RossiCancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data
FDA · cancer · 4 min
Dr. Elena RossiOwkin and AstraZeneca Enhance AI Collaboration for Drug Research
FDA · 4 min
Dr. Elena RossiHayes Receives 2026 ESMO Breast Cancer Award: Key Insights
FDA · breast cancer · 5 min
Dr. Elena RossiInsights from ESMO Asia: Nadia Harbeck on Oncology Advances
FDA · oncology · 4 min
Dr. Elena RossiCellectar Biosciences (CLRB) FDA Approvals, PDUFA Dates & Drug Alerts 2026
FDA · 5 min
Dr. Elena RossiBiosimilar Approvals: U.S. vs. Europe Insights for Pharma BD
FDA · 6 min
Dr. Elena RossiKey Cancer Drugs to Watch at ESMO 2025: Investor and BD Insights
FDA · cancer · 5 min
Dr. Elena RossiEuropean Navenibart Deal: A Strategic Win for BioCryst's Rare Disease Portfolio
FDA · rare disease · 4 min
Dr. Elena RossiTracy Beth Høeg's Departure: Implications for Pharma BD and Regulatory Teams
FDA · 6 min
Dr. Elena RossiEMA Horizon Scanning: Navigating Regulatory Updates for Future Medicines
FDA · 5 min
Dr. Elena RossiX4 Pharmaceuticals Secures Positive EMA CHMP Opinion for Mavorixafor in WHIM Syndrome
FDA · WHIM Syndrome · 5 min
Dr. Elena RossiExplore intelligence